Statements Opposing Drug Importation, 2000—

Download this 1-page reference list of letters opposing importation.

2019

National Consumers League, Statement on White House Pathway for Drug Importation, August 2, 2019

National Puerto Rican Chamber of Commerce, Statement in Response to Proposed Changes to Prescription Medication Importation Policies, August 1, 2019

California Life Sciences Association (CLSA), Response to Administration’s Drug Importation Plan, July 31, 2019

Canadian Pharmacists Association, Statement About U.S. Drug Importation, July 31, 2019

Pharmaceutical Industry Labor-Management Association, Statement on the Trump Administration's Exploration of Biopharmaceutical Importation, July 31, 2019

Alliance for Safe Online Pharmacies Canada, Best Medicines Coalition, Canadian Patient Safety Institute, Canadian Medical Association, Canadian Nurses Association, Canadian Organization for Rare Disorders, Canadian Pharmacists Association, Canadian Society of Hospital Pharmacists, Diabetes Canada, HealthcareCAN, Health Charities Coalition of Canada, McKesson Canada, Neighbourhood Pharmacy Association of Canada, OnPharm-United, and Shoppers Drug Mart/Loblaw Companies Limited, Letter to Canada's Minister of Health, The Honorable Ginette Petitpas Taylor, July 25, 2019.

Badger State Sheriffs' Association, Wisconsin State Sherrifs Association, Letters to Representatives Greg Walden and Frank Pallone, July 1, 2019.

American Pharmacists Association, National Association of Chain Drug Stores, National Alliance of State Pharmacy Associations, Letter to Alex M. Azar, II, Secretary of Health and Human Services, June 24, 2019

The Council for Citizens Against Government Waste, Statement to the President, May 9, 2019

The Council for Citizens Against Government Waste, Letter to Florida Governor Ron DeSantis, April 24, 2019

New Mexico State Board of Pharmacy, Letter to Members of Congress, April 22, 2019

Chamber of Commerce of the United States of America, Letter to United States Senate, April 9, 2019

Major County Sheriffs of America, Letter to Representatives Frank Pallone and Greg Walden of the House Energy & Commerce Committee, April 4, 2019

Alliance for Safe Online Pharmacies Global, Letters to the Florida Senate and House of Representatives, March 29, 2019 and accompanying graphic, February 2019

Alzheimer's & Dementia Resource Center, American Senior Alliance, Epilepsy Association of the Big Bend, Florida Osteopathic Medical Association, Florida Society of Clinical Oncology, Florida State Hispanic Chamber of Commerce, Oncology Managers of Florida, Partnership for Safe Medicines, Pharmacists United for Truth and Transparency, Salud USA, Sickle Cell Foundation, and The Epilepsy Association, Letter to Governor Ron DeSantis and the Florida Legislature, March 26, 2019

Lisa McElhaney, President, National Association of Drug Diversion Investigators, Statement to Members of the Health & Human Services Committee, Florida House of Representatives, March 11, 2019

Alliance for Safe Online Pharmacies, Letter to Members of the Health & Human Services Committee, Florida House of Representatives, March 11, 2019

Joint Statement of the Canadian Pharmacists Association (CPhA) and the American Pharmacists Association (APhA), February 2019

Freeh, Sporkin, and Sullivan LLC and the Freeh Group International, Addendum to the Report on the Potential Impact of Drug Importation Proposals on U.S. Law Enforcement, January 2019

Healthcare Distribution Alliance, Testimony, Oregon Senate Committee on Healthcare, January 30, 2019

The Oregon Pharmacy Coalition, Statement to the Oregon State Legislature, January 30, 2019

National Association of Chain Drug Stores, Letter to Senator Laurie Monnes Anderson, Chair, Oregon Senate Health Care Committee, January 28, 2019

Oregon Bioscience Association and Biotechnology Innovation Organization, Letter to Oregon State Senators Laurie Monnes Anderson and Dennis Linthicum, January 25, 2019

Northwest Association for BioMedical Research, Letter to Oregon State Senators Laurie Monnes Anderson and Dennis Linthicum, January 25, 2019

Alliance for Safe Online Pharmacies Canada, ASOP Canada Concerned by Impact of New U.S. Drug Importation Proposals on Canadian Drug Supply and Shortages, January 25, 2019

National Association of Chain Drug Stores and the American Pharmacists Association, Patient Safety Key as NACDS and APhA Oppose Prescription Drug Importation, January 18, 2019

2018

Nevada Sheriffs' & Chiefs' Association, Resolution Opposing Legislation on Drug Importation, November 8, 2018

The Partnership for Safe Medicines, Letter to Congress and President Trump, October 30, 2018

National Sheriffs’ Association, Letter to President Trump, August 8, 2018

Alliance for Safe Online Pharmacies, Statement Regarding the Announcement of a Drug Importation Working Group at FDA July 19, 2018

Secretary of Health and Human Services Alex Azar, Remarks on Drug Pricing Blueprint, May 14, 2018

The Association for Accessible Medicines, Testimony Opposing Vermont S. 175, February 5, 2018

Healthcare Distribution Alliance, Testimony Opposing Vermont S. 175, January 30, 2018

2017

International Association of Chiefs of Police, Resolution NDDC.013.T2017, December 2017

Alaska Pharmacists Association Executive Director Molly Gray to Sen. Lisa Murkowski. Nov. 8, 2017. [Consult PSM for a copy of the PDF]

American Society of Health-System Pharmacists, Letter to Senate Leadership, October 18, 2017

Nevada Sheriffs' and Chiefs' Association,  Letter from President Troy Tanner to Senator Dean Heller, September 21, 2017

National Sheriffs’ Association, Resolution 2017-00, July 28, 2017

National Association of Pharmacy Regulatory Authorities (Canada), Letter to U.S. Congress, June 26, 2017

California State Board of Pharmacy, Letter to Congress, June 19, 2017

Freeh, Sporkin, and Sullivan LLC and the Freeh Group International, Report on the Potential Impact of Drug Importation Proposals on U.S. Law Enforcement, June 6, 2017

American Pharmacists Association and the National Association of Chain Drug Stores, Letter to President Trump, June 5, 2017

The Partnership for Safe Medicines, Letter from the Board to the U.S. Senate, May 9, 2017

Louisiana Board of Pharmacy, Letter to Congress, April 25, 2017

Newfoundland and Labrador Pharmacy Board, Letter to Congress, April 21, 2017

The College of Pharmacists of Manitoba, Letter to Congress, April 10, 2017

American Pharmacists Association, Letter to Congress, March 22, 2017

The Kentucky Board of Pharmacy, Letter to Congress, March 17, 2017

The Arizona State Board of Pharmacy, Letter to Congress, March 17, 2017

The Oklahoma State Board of Pharmacy, Letter to Congress, March 17, 2017

Former FDA Commissioners, Drs. Robert Califf, Margaret B. Hamburg, Mark B. McClellan, and Andrew Von Eschenbach, Letter to Congress, March 16, 2017

The Virginia Board of Pharmacy, Letter to Congress, March 10, 2017

The West Virginia Board of Pharmacy, Letter to Congress, March 7, 2017

The Pew Charitable Trusts, Letter from Allan Coukell to Senator Bernie Sanders, February 28, 2017

The Partnership for Safe Medicines and 170 signatories, Letter to Congress, February 28, 2017

The National Association of Boards of Pharmacy, Letter to Congress, February 10, 2017

2016

The Best Medicines Coalition, Statement, March 2016

The Canadian Arthritis Patient Alliance, Statement, March 2016

2015

FDA Commissioner Robert Califf, Nomination Hearing, November 17, 2015

2014

The National Association of Boards of Pharmacy, Illegal Importation of Prescription Drugs (Resolution 110-1-14) , May 30, 2014

2012

Maine Attorney General William J. Schneider, declaring Maine's drug importation program in violation of Maine law, June 21, 2012

The Partnership for Safe Medicines and 33 co-signers, Letter to the U.S. Senate, May 21, 2012

2011

The Partnership for Safe Medicines, Letter to Senator David Vitter, October 19, 2011

2009

The Partnership for Safe Medicines, Letter to President Obama, April 8, 2009

Health and Human Services Secretary Kathleen Sebelius, Nomination Hearing, April 2, 2009

2007

Healthcare Institute of New Jersey, Editorial, October 15, 2007

The Canadian Pharmacists Association, the Ontario Pharmacists’ Association, the Best Medicines Coalition, and the Canadian Association for Pharmacy Distribution Management, Letter toTony Clement, the Canadian Minister of Health, January 12, 2007

2005

FDA Commissioner Lester M. Crawford, Nomination Hearing, March 17, 2005

2004

William K. Hubbard, Associate Commissioner for Policy and Planning, FDA, Letter to Governor Jim Doyle of Wisconsin, July 22, 2004

The National Association of Boards of Pharmacy, Illegal Importation – Federal and State Enforcement of Reimportation Laws (Resolution No. 100-1-04), April 28, 2004

The National Association of Boards of Pharmacy, Prosecution of Entities Aiding and Abetting in the Illegal Importation of Prescription Medications ( Resolution No. 100-17-04), April 28, 2004

2003

FDA Commissioner Mark B. McClellan, Letter to Senator Thad Cochran, June 19, 2003

The National Association of Boards of Pharmacy, Reimportation of Medications (Resolution No. 99-5-03), May 8, 2003

The National Association of Boards of Pharmacy, Position Paper on the Importation of Foreign Prescription Drugs, March 1, 2003

2001

Tommy Thompson, Secretary of Health and Human Services, Letter to Senator James Jeffords, July 9, 2001

2000

Donna Shalala, Secretary of Health of Human Services, Letter to President Clinton, December 26, 2000

Why not import medicine from online Canadian pharmacies?

Regulators Do Not Believe Importation Is Safe

Click here to read statements from the heads of HHS and FDA against allowing drug importation.

New To Counterfeit Drugs? Start Here.

A picture of pill bottles and blister packs of medicine